Predictors of inotrope use during separation from cardiopulmonary bypass

Kenneth H McKinlay1, David B Schinderle, Madhav Swaminathan

  • 1Division of Cardiothoracic Anesthesiology and Critical Care, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.

Insights

Six factors predict the need for inotropic support after heart surgery. These include specific echocardiographic findings and surgical details, aiding clinical decisions during cardiopulmonary bypass weaning.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Anesthesiology

Background:

  • Inotropic support is frequently required after cardiopulmonary bypass (CPB) during cardiac surgery.
  • Predicting the need for inotropic support can optimize patient management and outcomes.

Purpose of the Study:

  • To identify demographic, clinical, and echocardiographic predictors of inotropic support use at separation from CPB.
  • To establish a framework for anticipating and managing hemodynamic instability post-cardiac surgery.

Main Methods:

  • Retrospective analysis of 1009 patients undergoing coronary artery bypass graft (CABG) or combined CABG and valve surgery with CPB.
  • Intraoperative transesophageal echocardiography (TEE) was used to assess cardiac function.
  • Inotropic support defined by specific drug dosages (dopamine, epinephrine, norepinephrine, dobutamine, milrinone) or intra-aortic balloon pump (IABP) insertion.

Main Results:

  • 39% of patients required inotropic support upon separation from CPB.
  • Six independent predictors identified: Wall Motion Score Index, combined CABG and mitral valve surgery, left ventricular ejection fraction <35%, reoperation, moderate-to-severe mitral regurgitation, and aortic cross-clamp time.

Conclusions:

  • Intraoperative TEE findings, combined with clinical and surgical data, can reliably predict the need for inotropic support.
  • These predictors offer valuable insights for anesthesiologists and surgeons managing patients after CPB.
Abstract

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...